Use of Aromatase Inhibitors in Breast Carcinoma

Endocrine-Related Cancer - United Kingdom
doi 10.1677/erc.0.0060075
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Aromatase and COX in Breast Cancer: Enzyme Inhibitors and Beyond

Journal of Steroid Biochemistry and Molecular Biology
Molecular MedicineCell BiologyMolecular BiologyBiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2007English

Molecular Docking of Aromatase Inhibitors

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2011English

Carryover Effects of Aromatase Inhibitors in Prevention

The Lancet
Medicine
2020English

Prospective Characterization of Musculoskeletal Symptoms in Early Stage Breast Cancer Patients Treated With Aromatase Inhibitors

Breast Cancer Research and Treatment
Cancer ResearchOncology
2007English

Functional Genetic Polymorphisms in the Aromatase Gene CYP19 Vary the Response of Breast Cancer Patients to Neoadjuvant Therapy With Aromatase Inhibitors

Breast Diseases
OncologySurgery
2010English

The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2003English

Aromatase in Human Breast Carcinoma as a Key Regulator of Intratumoral Sex Steroid Concentrations

Endocrine Journal
EndocrinologyMetabolismDiabetes
2008English

Estrone Sulphate, FSH, and Testosterone Levels in Two Male Breast Cancer Patients Treated With Aromatase Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2010English

Immunohistochemical Detection of Aromatase in Breast Carcinomas

The Showa University Journal of Medical Sciences
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy